These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17638)

  • 1. Hydrolysis of a synthetic amide substrate by human C1 esterase (C1s).
    Morgan PH; Nair IG
    J Immunol; 1977 Jul; 119(1):19-25. PubMed ID: 17638
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of C1s and C4. A binding phenomenon.
    Taubman SB
    Biochim Biophys Acta; 1975 Jun; 393(2):542-55. PubMed ID: 125105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on the identification of the subcomponents of the first component of complement after affinity chromatography of human serum on IgG-sepharose.
    Taylor PA; Fink S; Bing DH; Painter RH
    J Immunol; 1977 May; 118(5):1722-7. PubMed ID: 858917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some enzymic properties of human lens esterase I.
    Swanson AA; Truesdale AW
    Invest Ophthalmol; 1974 Jun; 13(6):466-8. PubMed ID: 4208803
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: C1-esterase inactivators and C4 in malignant diseases.
    Bach-Martensen N; Osther K; Stroyer I
    Lancet; 1975 Sep; 2(7933):499-500. PubMed ID: 51308
    [No Abstract]   [Full Text] [Related]  

  • 6. A gross structure of an activated form of a subunit of the first component of human complement. Clr.
    Takahashi K; Nagasawa S; Koyama J
    FEBS Lett; 1975 Jul; 55(1):156-60. PubMed ID: 806475
    [No Abstract]   [Full Text] [Related]  

  • 7. The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex.
    Goers JW; Ziccardi RJ; Schumaker VN; Glovsky MM
    J Immunol; 1977 Jun; 118(6):2182-91. PubMed ID: 559020
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on serum factors mediating complement consumption by house dust allergens.
    Berrens L; Guikers CL; van Dijk AG
    Monogr Allergy; 1979; 14():150-4. PubMed ID: 503070
    [No Abstract]   [Full Text] [Related]  

  • 9. The identification of a previously unrecognized subcomponent of the first component of complement.
    Assimeh SN; Painter RH
    J Immunol; 1975 Aug; 115(2):482-7. PubMed ID: 807639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of an IgG fragment prepared with particulate plasmin to study the C1 binding and activation.
    Arlaud GJ; Meyer CM; Colomb MG
    FEBS Lett; 1976 Jul; 66(1):132-6. PubMed ID: 132372
    [No Abstract]   [Full Text] [Related]  

  • 11. C1, the first component of complement: structure-function-relationship of C1q and collectins (MBP, SP-A, SP-D, conglutinin), C1-esterases (C1r and C1s), and C1-inhibitor in health and disease.
    Loos M; Colomb M
    Behring Inst Mitt; 1993 Dec; (93):1-5. PubMed ID: 8172555
    [No Abstract]   [Full Text] [Related]  

  • 12. The human complement C1 complex has a picomolar dissociation constant at room temperature.
    Tseng Y; Zavodszky P; Schumaker VN
    J Immunol; 1997 Jan; 158(2):937-44. PubMed ID: 8993014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of two forms of activated C1s, a subcomponent of the first component of rabbit complement.
    Ishizaki E; Yoshioka Y; Mori Y; Koyama J
    J Biochem; 1976 Dec; 80(6):1423-7. PubMed ID: 1035218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).
    Windfuhr JP; Alsenz J; Loos M
    Mol Immunol; 2005 Apr; 42(6):657-63. PubMed ID: 15781109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of C1s-induced vascular leakage in guinea pigs by substituted benzamidine and pyridinium compounds.
    Andrews JM; Rosen FS; Silverberg SJ; Cory M; Schneeberger EE; Bing DH
    J Immunol; 1977 Feb; 118(2):466-71. PubMed ID: 320260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EAC4 and EAC14 production without purified Ci.
    Linscott WD
    J Immunol; 1975 Dec; 115(6):1625-30. PubMed ID: 241767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in activation of human and guinea pig complement by retroviruses.
    Bartholomew RM; Esser AF
    J Immunol; 1978 Nov; 121(5):1748-51. PubMed ID: 213489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage products of C4b produced by enzymes in human serum.
    Shiraishi S; Stroud RM
    Immunochemistry; 1975 Dec; 12(12):935-9. PubMed ID: 815169
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of the prime subsites of the C1s protease of the classical complement pathway for recognition of substrates.
    O'Brien G; Quinsey NS; Whisstock JC; Pike RN
    Biochemistry; 2003 Dec; 42(50):14939-45. PubMed ID: 14674770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trinitrophenylated red cells (E-TNP) as a model for antibody-independent activation of the complement system via the classical pathway.
    Loos M; Thesen R
    J Immunol; 1978 Jul; 121(1):24-8. PubMed ID: 670702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.